Cardiovascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Disease stocks.


Compare ETFs

    Recent Signals

    Date Stock Signal Type
    2021-05-05 AZNCF Fell Below 200 DMA Bearish
    2021-05-05 AZNCF NR7 Range Contraction
    2021-05-05 AZNCF Narrow Range Bar Range Contraction
    2021-05-05 AZNCF Stochastic Sell Signal Bearish
    2021-05-05 AZNCF Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-05-05 BGMD Fell Below 20 DMA Bearish
    2021-05-05 BGMD Narrow Range Bar Range Contraction
    2021-05-05 BGMD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-05-05 BTCY Crossed Above 50 DMA Bullish
    2021-05-05 BTCY MACD Bullish Centerline Cross Bullish
    2021-05-05 BTCY Pocket Pivot Bullish Swing Setup
    2021-05-05 CMPD Fell Below 20 DMA Bearish
    2021-05-05 CMPD Fell Below 200 DMA Bearish
    2021-05-05 CMPD Narrow Range Bar Range Contraction
    2021-05-05 CMPD MACD Bearish Signal Line Cross Bearish
    2021-05-05 CRTPF NR7 Range Contraction
    2021-05-05 CRTPF MACD Bearish Signal Line Cross Bearish
    2021-05-05 CRTPF Bollinger Band Squeeze Range Contraction
    2021-05-05 CRTPF 20 DMA Resistance Bearish
    2021-05-05 GNWSF Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-05-05 GNWSF Crossed Above 20 DMA Bullish
    2021-05-05 LXGTF Narrow Range Bar Range Contraction
    2021-05-05 NNBP Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-05-05 NNBP Calm After Storm Range Contraction
    2021-05-05 NNBP NR7 Range Contraction
    2021-05-05 NNBP Narrow Range Bar Range Contraction
    2021-05-05 NNBP Stochastic Sell Signal Bearish
    2021-05-05 RVXCF 50 DMA Resistance Bearish
    2021-05-05 RVXCF 200 DMA Resistance Bearish
    2021-05-05 RVXCF Bollinger Band Squeeze Range Contraction
    2021-05-05 RVXCF 20 DMA Support Bullish
    2021-05-05 SMLR Cup with Handle Other
    2021-05-05 SMLR Upper Bollinger Band Walk Strength
    2021-05-05 TBPMF Upper Bollinger Band Walk Strength
    2021-05-05 XRTXF Crossed Above 20 DMA Bullish
    2021-05-05 XRTXF Bollinger Band Squeeze Range Contraction

    Recent News for Cardiovascular Disease Stocks

    Date Stock Title
    May 5 TBPMF Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios
    May 4 TBPMF Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals
    May 3 SMLR Semler Scientific Inc. (SMLR) Q1 Earnings and Revenues Top Estimates
    May 3 SMLR Semler Reports First Quarter 2021 Financial Results
    May 3 TBPMF Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada
    May 1 AZNCF Is there a ban on Covid vaccine exports in the US?
    Apr 30 AZNCF FARXIGA Approved in the US for the Treatment of Chronic Kidney Disease in Patients at Risk of Progression With and Without Type 2 Diabetes
    Apr 30 AZNCF AstraZeneca Stock Jumps On Quarterly Beat, No Thanks To Its Covid Vaccine
    Apr 30 AZNCF 'Things are going to get much worse before they get better' in India: Expert
    Apr 30 AZNCF Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg
    Apr 30 AZNCF California has lowest COVID-19 case rate in the U.S.: RPT
    Apr 30 AZNCF Dow Jones Drops 200 Points As Stock Market Sells Off; Apple Hit With Antitrust Case
    Apr 30 AZNCF India sets another COVID case record, and Brazil’s health minister makes plea for vaccines
    Apr 30 AZNCF Pharma Stock Roundup: Big Drugmakers' Q1 Earnings, Resumption of JNJ US COVID-19 Jabs
    Apr 30 AZNCF Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days
    Apr 30 AZNCF UPDATE 2-In vaccine supply crunch, Mexico angles for 5 million doses from U.S.
    Apr 30 AZNCF European stocks struggle at the end of the month, as growth slows and earnings roll in
    Apr 30 AZNCF Why AstraZeneca Stock Is Jumping Today
    Apr 30 AZNCF Alexion (ALXN) Tops Q1 Earnings, Merger With AstraZeneca On Track
    Apr 30 AZNCF AstraZeneca (AZN) Q1 Earnings Top, COVID-19 Vaccine Adds $275M

    Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. CVD includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes mellitus, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure is estimated to account for approximately 13% of CVD deaths, while tobacco accounts for 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that up to 90% of CVD may be preventable. Prevention of CVD involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together CVD resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Diagnosis of disease typically occurs seven to ten years earlier in men as compared to women.

    More about Cardiovascular Disease
    Browse All Tags